Mythbusting the Modern Data Catalog

Logo
Presented by

Paige Bartley Sr Analyst Data, AI, & Analytics 451 Research | Aaron Kalb Co-founder & CDO Alation

About this talk

Does a data catalog eliminate data silos? Can there be a data catalog to 'rule them all'? 451 Research and Alation separate fact from fiction on these myths and more. More and more enterprises are turning to data catalogs to drive digital transformation and create a thriving data culture. As demand for data catalogs has grown, however, some common ‘myths’ have arisen. Watch this on-demand webinar to find out which myths are fact and which are fiction. Paige Bartley, senior analyst for data, AI, and analytics, 451 Research, and Aaron Kalb, co-founder and CDO, Alation, examine the top-four assumptions about data catalogs. Backed by the latest research from 451 Research and real-world customer feedback, Paige and Aaron dive into these common myths: Myth #1: A data catalog is either for governance or analytics, not both Myth #2: Data analysts waste huge amounts of time just looking for data Myth #3: A data catalog alone will eliminate the problems associated with data silos Myth #4: There can be a single enterprise catalog to 'rule them all'
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (106)
Subscribers (17398)
Alation is the leader in enterprise data intelligence solutions, including data search & discovery, data governance, data stewardship, analytics, and digital transformation. Alation’s initial offering dominates the data catalog market. Thanks to its powerful Behavioral Analysis Engine, inbuilt collaboration capabilities, and open interfaces, Alation combines machine learning with human insight to successfully tackle even the most demanding challenges in data and metadata management. More than 500 enterprises drive data culture, improve decision-making, and realize business outcomes with Alation, including AbbVie, American Family Insurance, Autozone, Cisco, Draft Kings, Exelon, Fifth Third Bank, Finnair, Munich Re, NASDAQ, Parexel, Pfizer, Salesforce, Virgin Australia, and Vistaprint.